OH2 Injection: Clinical Trials

8 trials of OH2 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 terminated, 1 not yet recruiting. 7 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 2, Recruiting 2, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 26Completed 2, Terminated 2, Recruiting 1, Unknown 1

Follow OH2 Injection: new trials by email Literature Review of OH2 Injection trials Research Report on OH2 Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OH2 Administered by Intratumoral Injection
OH2 Injection - Solid Tumor
Phase 1Not yet recruitingBinhui Biopharmaceutical Co., Ltd.292025-09-012024-12-27
OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
OH2 injection - Advanced Liver Cancer
Phase 1RecruitingBinhui Biopharmaceutical Co., Ltd.122023-05-052024-12-20
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
OH2 injection - Non-muscle-invasive Bladder Cancer
Phase 1 / Phase 2UnknownBinhui Biopharmaceutical Co., Ltd.302022-07-112024-08-12
OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer
OH2 injection - Advanced Bladder Carcinoma
Phase 2TerminatedBinhui Biopharmaceutical Co., Ltd.42022-05-252025-08-03
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
OH2 injection - Central Nervous System Tumors
Phase 1 / Phase 2CompletedBinhui Biopharmaceutical Co., Ltd.402021-11-162026-08-05
OH2 Oncolytic Viral Therapy in Pancreatic Cancer
OH2 injection - Pancreatic Cancer
Phase 1 / Phase 2TerminatedBinhui Biopharmaceutical Co., Ltd.52021-02-022023-11-24
OH2 Injection in Combination With HX008 for Melanoma.
OH2 injection, HX008 injection - Melanoma
Phase 1 / Phase 2RecruitingBinhui Biopharmaceutical Co., Ltd.602020-12-012025-07-24
OH2 Injection in Solid Tumors
OH2 injection, Keytruda - Solid Tumor, Melanoma
Phase 1 / Phase 2CompletedBinhui Biopharmaceutical Co., Ltd.442018-11-222026-08-06

Conditions studied

Melanoma (2)  ·  Central Nervous System Neoplasms (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Binhui Biopharmaceutical Co., Ltd. (8)

Countries

China (7)

Results publications

PMID 38537773, PMID 39915002